Abstract:9‐amino‐8‐bromo‐3,4‐dihydroacridin‐1(2H)‐one (KY‐31) displayed relatively low toxicity and retained anti‐inflammatory activity with a higher selectivity index compared to 9‐aminacrine (9‐AA). It may exert its anti‐inflammatory effects through the nuclear receptor subfamily 4 group A member 1 (NR4A1)/Interleukin‐10 (IL‐10)/suppressors of cytokine signalling 3 (SOCS3) signaling pathway and inhibit the protein targets phosphodiesterase‐4 (PDE‐4) and p38 mitogen‐activated protein kinases (MAPK). These findings support further development and exploration of 9‐amino‐8‐bromo‐3,4‐dihydroacridin‐1(2H)‐one as a promising anti‐inflammatory compound for inflammatory conditions. 9‐aminacrine (9‐AA), an external antibacterial agent, possesses important bioactivities for the treatment of cancer, viruses, and prion diseases. Recent research has revealed that 9‐AA has anti‐inflammatory effects through the up‐regulation of nuclear receptor subfamily 4 group A member 1 (NR4A1), but it is highly cytotoxic. To mitigate its toxicity, three series of novel 9‐AA derivatives were synthesized. The toxicity of all compounds was assessed, and some of the less toxic compounds were tested for in vitro anti‐inflammatory activities, leading to the establishment of structure‐activity relationships. In particular, 9‐amino‐8‐bromo‐3,4‐dihydroacridin‐1(2H)‐one exhibited relatively low toxicity and retained anti‐inflammatory activity, with a higher selectivity index compared to 9‐AA (3.44 versus 0.68). Expression experiments of inflammatory mediators revealed that this compound not only inhibited the gene expression of pro‐inflammatory factors, but also promoted the gene expression of anti‐inflammatory factors. Preliminary mechanistic studies suggested that it exerted anti‐inflammatory effects through the NR4A1/Interleukin‐10 (IL‐10)/suppressors of cytokine signalling 3 (SOCS3) signaling pathway. Furthermore, molecular docking studies indicating that it may exhibit anti‐inflammatory activity by inhibiting the protein targets phosphodiesterase‐4 (PDE‐4) and p38 mitogen‐activated protein kinases (MAPK). Based on our data, 9‐amino‐8‐bromo‐3,4‐dihydroacridin‐1(2H)‐one with its low toxicity and anti‐inflammatory properties, holds promise for further development as an anti‐inflammatory agent.

Δ-Amyrone, a Specific Inhibitor of Cyclooxygenase-2, Exhibits Anti-Inflammatory Effects in Vitro and in Vivo of Mice

Δ-Amyrone Inhibits Lipopolysaccharide-Induced Inflammatory Cytokines and Protects Against Endotoxic Shock in Mice.

Isoacteoside, a Dihydroxyphenylethyl Glycoside, Exhibits Anti‐inflammatory Effects Through Blocking Toll‐like Receptor 4 Dimerization

Anti-inflammatory effects and related mechanisms in vitro and in vivo of Hedychium coccineum rhizome essential oil

(9S,13R)-12-oxo-phytodienoic acid attenuates inflammation by inhibiting mPGES-1 and modulating macrophage polarization via NF-κB and Nrf2/HO-1 pathways

Protective Effect of Δ-Amyrone Against Ethanol-Induced Gastric Ulcer in Mice

Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents

Phenolics and terpenoids with good anti-inflammatory activity from the fruits of Amomum villosum and the anti-inflammatory mechanism of active diterpene

Synthesis and Evaluation of 2-Cyano-3, 12-Dioxooleana-1, 9(11)-En-28-oate-13β, 28-Olide As a Potent Anti-Inflammatory Agent for Intervention of LPS-induced Acute Lung Injury

Synthesis and Anti-Inflammatory Activity of the Natural Cyclooxygenase-2 Inhibitor Axinelline A and Its Analogues

Effects of Chelerythrine, a Specific Inhibitor of Cyclooxygenase-2, on Acute Inflammation in Mice.

Anti-Inflammatory Activities Of An Herbal Formula Ky079

Isolation and characterization of phellodendronoside A, a new isoquinoline alkaloid glycoside with anti-inflammatory activity from Phellodendron chinense Schneid

Anti-Inflammatory, Antinociceptive Activity of an Essential Oil Recipe Consisting of the Supercritical Fluid Co2 Extract of White Pepper, Long Pepper, Cinnamon, Saffron and Myrrh in Vivo

Esculentic Acid, a Novel and Selective COX-2 Inhibitor with Anti-Inflammatory Effect in Vivo and in Vitro

Dysiarenone from Marine Sponge Dysidea arenaria Attenuates ROS and Inflammation via Inhibition of 5-LOX/NF-κB/MAPKs and Upregulation of Nrf-2/OH-1 in RAW 264.7 Macrophages

Design, Synthesis, Biological Evaluation and Docking Study of A New Series of 9‐aminoacridine Derivatives as Anti‐inflammatory Agents

Anti-inflammatory and anti-oxidant properties of Melianodiol on DSS-induced ulcerative colitis in mice

CHP1002, a Novel Andrographolide Derivative, Inhibits Pro-Inflammatory Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Expressions in RAW264.7 Macrophages Via Up-Regulation of Heme Oxygenase-1 Expression.

Anti-inflammatory Effects of Cavidine In Vitro and In Vivo , a Selective COX-2 Inhibitor in LPS-Induced Peritoneal Macrophages of Mouse

Eremophilane and cadinane sesquiterpenoids from the fruits of Alpinia oxyphylla and their anti-inflammatory activities